In an effort to better understand the consequences of lead (Pb'+) on skeletal growth, the effects of Pb*+ were investigated using ROS 17/2.8 bone-like cells in vitro. These studies revealed that Pb2+ (4.5 X 10m6 M -4.5 X 10M7 M) has little or no effect on cell shape except when added immediately following seeding of the cells. However, proliferation of ROS cells was inhibited, in the absence of serum, at concentrations of 4.5 X 10m6 M Pb*+. Protein production was generally increased, however, the major structural protein of bone, type I collagen, production was only slightly altered. Following treatment of ROS cells with Pb*+, intracellular levels of the calcium-binding protein osteonectin/ SPARC were increased. Osteonectin/SPARC secretion into the media was delayed or inhibited. Coincident with retention of osteonectin/SPARC there was a decrease in the levels of osteonectin/SPARC mRNA as determined by Northern analysis. These studies suggest that processes associated with osteonectin/ SPARC translation and secretion are sensitive to Pb2+. o 1992 Academic Press, Inc.
Lead (Pb") is a toxic substance that is known to impair skeletal growth even at levels of exposure for the general population (0.75 PM) (Mooty et al., 1975; Angle and Huseman, 1989; Shukla et al., 1989; Schwartz et al., 1986; Frisanch and Ryan, 1991) . There are several indications that Pb2+ by its interactions with calcium (Ca2+) may perturb many normal calcium regulatory processes, e.g., its action as a second messenger, interactions with calcium binding and other extracellular proteins associated with mineralized tissues and subcellular functions at the level of the mitochondria, synaptosomes, and membrane vesicles. Furthermore, lead is known to affect protein synthesis (Shelton et al., 1986) , particularly by increasing proteins that constitute nuclear and cytoplasmic inclusion bodies (Moore et al., 1973; Richter et al., 1968; Choie et al., 1975; McLachlin et al., 1980; Shelton and Egle, 1982) , two glucose regulated proteins (Shelton et al., 1986) and by deminishing the levels of the bone related protein, osteocalcin (Angle et al., 1990; Long et al., 1989 Long et al., , 1990 .
In addition to osteocalcin, there is increasing evidence that other noncollagenous proteins associated with mineralized tissues play a critical role in the regulation of osteogenesis. This has led to increased research emphasis on purifying, characterizing, and identifying the role of these proteins in the mineralization process (for reviews see Butler 1985; Fisher et al.. 1987; Glimcher and Lian, 1989) . Many of these proteins are acidic and are known to bind both Ca2+ and hydroxylapatite, suggesting a role for them in the initial phases of mineralization.
Also, some bone related proteins such as osteonectin/SPARC (secreted protein, acid and rich in cysteine) mRNA have been localized to areas of active tissue morphogenesis and are expressed in cells and tissues that exhibit high rates of turnover, secretion, and remodeling (Funk and Sage, 199 1) . In the studies reported here we seek to determine if Pb2+ alters the characteristics of ROS 17/2.8 bone-like cells in vitro. Also, this study determines whether Pb2+ affects the production of two recognized bone matrix components, collagen and osteonectin/SPARC.
Furthermore, we examine the effect of Pb2+ on Hsp47, a resident endoplasmic reticulum protein of cells producing type I collagen (Nakai et al., 1990; Sauk et al., 1990b) .
MATERIALS AND METHODS
Cell culture. Cloned bone cell lines (ROS 17/2.8) derived from AC19935 rat osteosarcoma were used. These cells have the advantage that their osteoblastic-like phenotypic characteristics are maintained in vitro (Majeska et al.. 1980) . Cells were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 1.16 g/l glutamine, 100 units/ml penicillin, 100 &ml streptomycin, and 10% fetal bovine serum (FBS). Lead glutamate was prepared by preparing a stock solution containing 4.5 X lo-' M lead nitrate (Sigma) and 5.0 X lo-' M glutamic acid in water.
Proliferation rate.
~8.0 X lo3 cells/well. with DMEM supplemented with 10% FBS and antibiotic and incubated overnight at 37°C. On the following day, the medium was removed from each well and medium added as follows: (a) DMEM + 10% FBS + glutamic acid; (b) DMEM + 2% FBS + glutamic acid; (c) DMEM + 0% FBS + ghrtamic acid; (d) DMEM + 2% FBS t lead glutamate; and (e) DMEM t 0% FBS + lead glutamate. The effects of lead glutamate on cell proliferation were evaluated at three different concentrations, 4.5 X lo-' M, 4.5 X 10m6 M and 4.5 X lo-' M. Cell proliferation, on Day 2, Day 4. and Day 6 after seeding, was determined by trypsinizing cells and counting electronically using a Coulter counter. Determination of total protein and collagen production. The methods for labeling cells have been reported previously (Somerman et al.. 1987) . Briefly, 1.0 X lo4 cells per test well (Falcon, 35-mm wells) were seeded in wells in DMEM with 10% FBS and antibiotics. After cells attached and spread, medium was removed and cells were incubated for 48 hr in serumfree DMEM with 20 &i/ml L-5-[3H]proline and (a) glutamic acid (control) or(b) 4.5 X 1O-6 M lead glutamate. Media and cell samples were then dialyzed extensively against cold buffer (pH 7.4,0.05 M Tris-HCI, 0.2 M NaCI, 0.005 M CaCl,). Following dialysis, aliquots of these samples were counted in a liquid scintillation spectrometer (Packard Tri Carb 460C) in Aquasol-(New England Nuclear (NEN) Boston. MA). These counts represented total nondialyzable radioactive material and were taken as a measure of total protein production.
To estimate collagen production, an ahquot of the above dialyzed material was reacted for 6 hr at 37°C with chromatographicahy purified bacterial collagenase (Form III, Advance Biofactures) according to methods of Peterkofsky and Diegelmann ( 197 1). Undigested proteins were precipitated with 5% trichloroacetic acid/0.5% tannic acid and samples were centrifuged. An aliquot of the supernatant was counted in Aquasol-(NEN) with a liquid scintillation counter. To provide a background value for the collagenase assays, additional aliquots of dialyzate were treated as above except that bacterial collagenase was excluded from these samples. The resulting backgrounds were subtracted from the collagenase-treated series to yield a value which represented collagen production expressed as collagenase digestible protein.
To determine the effects of lead on protein synthesis, cells were incubated with 35S-methionine and 4.5 X 10m6 M lead glutamate for 20 min and then cell and media were harvested separately, as described above. Nonradioactive wells were run in parallel with these experiments to obtain total number of cells/well at time of harvest. The cells were harvested with 0.08% trypsin/ 0.04% EDTA and total cell number per well was determined electronically by Coulter counter. All assays were run in triplicate and data expressed as CPM X I Om3/ 1 O6 cells.
Gel electrophoresis. For polyacrylamide gel electrophoresis (PAGE), cells were seeded and exposed to 4.5 X 1 Om6 M lead glutamate and radioactively labeled exactly as described above. Media and cell samples were dialyzed extensively against distilled water and lyophilized. Comparable cell and media samples, of control and lead-treated cells. were dissolved in gel buffer. Thus, any variation in protein profiles among samples is based on altered protein production/well during the labeling period. Following reduction with mercaptoethanol, the samples were analyzed by gel electrophoresis on SDS 4-20% polyacrylamide gradient slab gels according to the method of Laemmli (1970) . The gels were fixed, dried, and autoradiographed using the method of Bonner and Laskey (1974) .
Zmmunoblotting. For Western blots. 3 X lo6 cells were plated and SDS-PAGE was performed as described above and proteins were immediately electrotransferred to nitrocellulose paper (Towbin et al., 1979) . The paper was blocked with 3% bovine serum albumin (BSA) in 10 mM Tris-HCl, pH 7.4.0.9 M NaCl (TBS) for 1 hr and then in TBS/BSA with 2% normal goat serum (NGS-GIBCO). Antiserum, rabbit-anti-bovine osteonectin (gift of L. Fisher NIDR/NIH), or preimmune serum were diluted 1:2000 in the same solution and incubated with gentle shaking overnight. The nitrocellulose paper was then rinsed three times for 5 min in TBS/Tween. The secondary antibody, affinity-purified goat-anti-rabbit IgG (Fc) horseradish peroxidase (Kirkegaard & Perry Labs, Inc., Gaithersburg, MD) was diluted to 0.9 pg/ ml and incubated with the paper for 2 hr. Washing between steps was performed three times for 30 min with 50 mM Tris-HCl, 0.9 M NaCI, 0.05% Tween, pH 7.4. Staining was accomplished with 4-chloro-naphthol. For Hsp47, polyclonal rabbit antibodies were prepared against a 22-mer peptide corresponding to the N-terminal sequence of chick Hsp47 (Hirayoshi et al.. 199 1) that was conjugated to Keyhole limpit hemocyanin (Sauk et al., 1990b) .
Zmmunoprecipitation.
Cell layers having equal cell numbers were homogenized in 2X immunoprecipitation buffer (0.2 M Tris-HCI, 0.3 M NaCl., 2% Triton X-100, 2% deoxycholate, 0.2% SDS, pH 7.2) and diluted with cold distilled water to 1 X. while the culture media was diluted 3: 1 with 4X immunoprecipitation buffer. The homogenates and media were then centrifuged for 5 min at 10,OOOg in an Eppendorfcentrifuge and a 50-r] sample of the radiolabeled supernatant was added to a mixture of GammaBind GAgarose (Genex, Gaithersburg, MD) and antibody in PBS-azide. The samples were then incubated at 4°C with constant shaking and then centrifuged at 10,OOOg for 10 min. The resulting immunoprecipitate pellets were then washed twice with PBS-azide. The final pellets were suspended in 2X gel electrophoresis sample buffer, heated for IO min at 90°C. and then centrifuged to remove GammaBind G-agarose. Samples ofthe supematants were counted in a scintillation counter and another sample analyzed by PAGE and autoradiography as described above. Autoradiograms were densitometrically scanned and data were reported as ratio of treated to control samples.
Northern analysis. Total RNA from 4 X lo6 ROS 17/2.8 cells was solubilized in 500 ~14 M guanidinium thiocyanate containing 25 mM sodium acetate (pH 5.0) and 100 IIIM fl-mercaptoethanol, transferred to an Eppendorf tube containing 20-pg of calf liver tRNA, and precipitated by addition of 450 r.d of 100% ethanol. RNA pellets were reprecipitated in the presence of 80% ethanol containing 100 mM sodium acetate (pH 5.0) at -20°C. and equal amounts of RNA were immediately loaded onto Northerns. RNA was transferred to nitrocellulose and bound to the paper by baking at 80°C for 2 hr in YYZUU. A 1.5-kb EcoRI restriction fragment of a bovine osteonectin cDNA (Sauk et al.. I99 1) was radiolabeled by nick translation (Amersham Kit) using cu-[P3'] dCTP and hybridized to filter bound RNA. Hybridization was carried out at 37°C in a mixture of 40% formamide, 0.1 g/ml dextran sulfate, 5X SSC (74 mM sodium citrate, 750 mM sodium chloride), 10 mM Tris (pH 7.5). 4X Denhardt's solution, and 0.1 mg/ml denatured salmon sperm DNA. The filters were washed in a solution of 2X SSC. 0.1% SDS three times for I5 min at 25°C and autofluorographed. Values of the osteonectin/SPARC mRNA (arbitrary densitometric units) were normalized to the amount of ribosomal RNA.
Attachment assay. The attachment assay utilized is similar to that of Klebe (1974) . Uncoated polystyrene bacteriological 24-well plates (bacteriological petri dishes. 25820 special Corning) containing the specific factor being evaluated. i.e., fibronectin (10 &ml, positive control) or lead glutamate at a concentration of 4.5 X 10e6 M and 4.5 X lo-' M, were preincubated for 1 hr at 37°C in 0.4 ml DMEM containing I mg/ml bovine serum albumin (BSA, Fraction V Miles Laboratories, Inc.). Control wells had DMEM plus BSA. Following the conditioning period ROS 17/2.8 cells. at a concentration of 3 X IO" cells in 0.1 ml of DMEM/BSA were added to the wells. Incubation was continued for an additional 90 min and wells were rinsed with Hanks' balanced salt solution to remove unattached cells. Photographs, as needed, were taken at this time to document cell spreading. Cells remaining were removed enzymatically with 0.08% trypsin/0.04% EDTA and counted electronically using a Coulter counter.
Cell spreading. Cell spreading was determined by photographing six representative microscopic fields at X10. The photographic images were then captured using an ELM0 visual presenter (EV-368) and the shape of the resulting cells was determined following image analyses using NIH Image ( I .40) software.
Statistical analyses. All experiments consisted of at least triplicate determinations. The statistical significance of differences in effects of Pb2+ on cells was determined by analysis of variance and Duncan's multiple range test. For proliferation studies cells were exposed to three concentrations of Pb2+, 4.5 X 10e5 M, 4.5 X 10m6 M, and 4.5 X 10m7 M in DMEM/2% FBS or DMEM/O% FBS. After 1 day exposure of cells to 4.5 X 10m5 M Pb2+ in DMEM/O% FBS a visible precipitate was noted. By Day 4 a similar precipitate was noted in cells exposed to 10e5 M Pb2+ in DMEM/2% FBS and a decrease in cell proliferation was noted compared to controls (Fig. 1) . Concentrations of Pb*+ less than 4.5 X 10e5 M had no effect on cell proliferation in the presence of serum. However, in the absence of serum, 4.5 X 10m7 M Pb*' increased cell proliferation at Day 4 while, 4.5 X 10e6 M Pb*+ inhibited proliferation, but not until Day 6.
RESULTS
The in vitro attachment assay revealed that Pb2+ (4.5 X lop6 M-4.5 X lo-* M) did not affect cell attachment. Furthermore, fibronectin attached cells were not displaced by the addition of Pb*+ to the media (Table 1) . However, if Pb*+ (4.5 X 10m6 M) was incorporated into the medium of cells within the first 3 hr, 92 ? 3% the cells that attached did not go on to spread (Fig. 2A) . This nonspread condition persisted for up to 4 days, after which the experiment was terminated. If the cells were allowed to attach and spread overnight, Pb*+ added to the medium did not affect spreading, consequently 85 * 9% of Pb2+ treated and 87 + 6% of control cells were noted to spread (Fig. 2) .
Based on proliferation and attachment results, Pb*+ at 4.5 X lop6 M was added 24 hr after plating and used in assays designed to determine the effect of Pb2+ on biosynthetic ac- tivity of ROS 17/2.8 cells, in vitro. Both media and cells nificant increase in collagen production was observed (Table exposed to Pb2+ for 48 hr exhibited a significant increase in 2). To determine whether Pb2+ had a short-term effect on total protein production/cell, approximately 30 and 40%, cellular proteins (i.e., protein synthesis) ROS 17/2.8 cells respectively, when compared to control. In contrast, no sig-were exposed to 4.5 X 10e6 M Pb2+ for 20 min and radio- actively labeled during this time period. As seen in Table 3 , Pb2+ exposed cells exhibited an increase in protein synthesis, but not in secreted (media) proteins. To further investigate these changes, we analyzed the effect of varying Pb2+ concentrations on cellular levels of Hsp47, a collagen-binding glycoprotein associated with collagen assembly and sorting, and on the acidic bone-related protein, osteonectin/SPARC.
Hsp47 levels, as with collagen production, were not altered by Pb2+ treatment (Fig. 3) . Conversely, cellular levels of osteonectin were noted to be enhanced following Pb2+ exposure (Fig. 4) . Examination of the media following Pb2+ (4.5 X low6 M) treatment revealed that osteonectin/SPARC levels were not detectable, by optical density comparison, to that of control cells (Fig. 5) . Exposure of ROS 17/2.8 cells to 4.5 X 10p5-4.5 X 10e7 M Pb2+ for a shorter duration (20 min) followed by immunoprecipitation of cell proteins with anti-osteonectin antibodies revealed a dose-dependent decrease in synthesis of osteonectin/SPARC (Fig. 6 ). Northern analysis of osteonectin mRNA (2.2 kb) showed no differences between Pb*+ treated (4.5 X lop6 M) for 1 hr and control cells. However, if cells were exposed to PbZf for 24 hr, osteonectin/SPARC mRNA levels were reduced by threefold compared to control cells (Fig. 7) .
DISCUSSION
The data reported here demonstrate that Pb2+ decreases the proliferation of bone cells in vitro and enhances cellular protein production. The ability of Pb2+ to decrease ROS 17/ 2.8 proliferation is in agreement with similar studies by Long et al. (1990) . However, at comparable doses (4.5 X 10m6 M) we observe decreased cell growth by Day 6, whereas Long et al. did not observe decreased cell growth until Day 9. The reason for these differences may include the experimental design. Although both studies used ROS 17/2.8 cells, we used 0 and 2% serum whereas they used 5% serum. Higher serum levels may lower the concentration of unbound Pb*+ available to cells. We also used lead glutamate, while they used lead acetate which is particularly prone to form precipitates (McLachlin et al., 1980) . The importance of cell adhesion in the regulation of many physiological and pathological events including development, platelet aggregation, wound healing, and malignant invasion prompted us to further investigate the effects of Pb2+ on bone cell attachment. The adhesion of cells to a substratum, in vitro is frequently regulated by calcium dependent, receptorligand interactions. Thus a reasonable hypothesis for the observed decreased cell attachment would be that Pb2+, by competing with Ca2+ at the cellular membrane, may interfere with receptor-ligand interactions and subsequently cell attachment and spreading. Previous studies reported that marrow cells exposed to Pb2+ ( 1 -10 PM Pb2+) for 10 days exhibited decreased adherence to tissue culture dishes (Kowolenko et al., 1989) . The ability for ROS 17/2.8 cells to attach, but (Nakai et al., 1990) . The optical density of precipitates in Western blots and bands in immunoprecipitate autoradiograms were determined by gel scanner as a component of NIH Image (I .4) software. These analyses revealed relative optical density differences of co.05 between control and Pb2+ treated cells.
not spread following the early on addition of Pb2+ indicates that these events, in bone cells, are temporally mediated. Also, once spreading has developed Pb2+ cannot reverse this process. However, in our studies, no effect on cell attachment was noted in distinction to effects observed with marrow cells (Kowolenko et al., 1989) . Furthermore, cells already attached through a calcium dependent integrin receptor-fibronectin interaction were not detached by doses of PbZf that were sufficient to alter protein production and cell proliferation. The separate modulation of cell spreading and proliferation has been noted previously. Funk and Sage ( 199 1) showed that SPARC inhibited cell proliferation and caused cell rounding of endothelial cells. Furthermore, inhibition of cell doubling was attributed to a 20-residue synthetic peptide (2.1) derived from a non-Ca2+-binding, disulfide-rich region of SPARC, while cell rounding was promoted by sequences 5-23 in the calcium-binding region of the molecule. In the present study, there was no secretion of osteonectin/SPARC to cause cell rounding in the first few hours. However, Pb2+ might alter a membrane receptor, ion pump, or disturb a second messenger system (Borke et al., 1988; Busselberg et al., 199 1) controlling cell shape.
Lead's ability to modulate both the synthesis and production of proteins by ROS 17/2.8 cells appears to be directed at least in part to acidic calcium binding proteins. Thus. collagen and Hsp47 levels are unchanged whereas cellular levels of osteonectin/SPARC are enhanced and secretion similar to osteocalcin (Angle et al., 1990; Long et al., 1989 Long et al., , 1990 ) is inhibited. However, the increased cellular levels of osteonectin/SPARC ensue while synthesis, depicted by shortterm 35S-methionine labeling, is diminished. Shelton et al. (1986) similarly demonstrated that Pb2+ enhances the level of an acidic (p1 6.3) inclusion body protein in kidney cells, and Fowler et al. (1985) showed increases in the synthesis of acidic gene products in rats given a single low dose of Pb2+ which induced intranuclear inclusions in renal proximal tubule cells. However, unlike the Pb2+-induced nuclear proteins, osteonectin/SPARC is secreted, though delayed, in the presence of Pb2+ and is found in the medium. Lead inhibits this release possibly by affecting the conformation of osteonectin/SPARC as well as other acidic calcium-binding proteins. As a result, these proteins are retained in the ER. The inhibition or delayed secretion of structurally altered proteins is common and delayed synthesis, even in the presence of equivalent levels of mRNA, may ensue as a consequence of retention or delayed secretion of protein from the ER (Byers, 1990) .
The diminished levels of osteonectin/SPARC mRNA in cells treated with Pb'+ for 24 hr signifies that pretranslational events controlling these acidic cellular proteins may also be affected by Pb2+. The accumulation, over time, of PbZf in the nucleus (Shelton, 1986 ) may place Pb*+ in proximity to transcriptional events. Proteins such as p2 l/6.2, associated with nuclear matrices, have been implied in affecting DNA replication, RNA transcription, mitogenesis, and cell proliferation (Mistry et al., , 1986 Klann and Shelton, 1989; Fowler and Duval, 199 I) . Candidates for posttranscription and/or pretranslational affects of Pb2+ include the ~220 component of an eukaryotic initiation factor 4F and regucalcin-like proteins. The ~220 component functions in the first step of the binding of capped mRNAs to the small ribosomal subunit and has been shown to be a substrate for multiple calcium-dependent enzymes (Wyckoff et al., 1990) . Regucalcin, a calcium-binding protein derived from cytosol, regulates Ca+* mediated cell function by inhibiting aminoacyl-tRNA synthetase activity (Yamaguchi and Mori, 1990) .
Thus. these studies demonstrate further that Pb"+ has a pleiotropic effect on bone cells. ER processes, possibly associated with calcium-dependent protein folding, appear to be sensitive to Pb+*, resulting in retention or delayed protein secretion. In contrast, receptor-mediated attachment to substratum is undisturbed by Pb2+. Future studies directed at establishing the mechanism for the alteration of specific bone proteins in cells exposed to Pb*+ are warranted and will help to clarify the effect of Pb2+ on bone growth and possibly provide a molecular marker for Pb*+ exposure in the environment.
